Researchers from UC San Diego have found that pharmacists and female pharmacy technicians are more likely to die by suicide. Findings emphasize need for more mental health support for health care workers. Click here to […]
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in […]
UC San Diego researchers have developed a groundbreaking “one-click” AI tool that could transform how doctors plan specialized radiation treatments for cervical cancer, saving physician time, reducing patient discomfort and minimizing the risk of human […]
UC San Diego has received a $7.4 million grant to support the development of a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia, a rare inherited neurodegenerative disease that causes progressive loss of coordination, muscle […]
Offering strengthens support to IVD developers across development and clinical research programs CARLSBAD, Calif., Jan. 8, 2026 /PRNewswire/ — DCN Dx, a specialist in diagnostics development, manufacturing, regulatory consulting, and clinical research, today announced the […]
Solution Provides Self-Guided Tools Broadening Member Options for Recovery SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — American Specialty Health (ASH), a leader in musculoskeletal (MSK) health care, has launched a major enhancement to its digital […]
Facility Enters Qualification to Support Late?Stage Pivotal Manufacturing and Commercial Readiness SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — Aspen Neuroscience, Inc., a clinical?stage biotechnology company pioneering autologous regenerative therapies, today announced completion of Cohort… Click […]
SAN DIEGO–(BUSINESS WIRE)–Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced additional results from the older adult follow-on cohorts from its completed Phase 1 trial evaluating MF-300, […]
PHILADELPHIA & CARLSBAD, Calif.–(BUSINESS WIRE)–Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that they have entered into a […]
Company to receive approximately $7 million in funding from the Gates Foundation to use its srRNA platform to develop malaria and HIV candidates to address two of the world’s most persistent public health burdens, subject […]
Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: […]
SAN DIEGO–(BUSINESS WIRE)–Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), today announced continued clinical progress with cizutamig (BCMA TCE) and CND261 (CD20 […]
A study of people with auto-brewery syndrome — a rare condition causing intoxication without drinking alcohol — has found a link between gut microbes and symptoms, pointing to new treatment strategies. Click here to view […]
CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida Biosciences […]
SAN DIEGO & BOSTON & BILBAO, Spain–(BUSINESS WIRE)–Artis BioSolutions (“Artis”), a San Diego-based advanced-therapies development and manufacturing company, today announced that it has entered into a definitive agreement to acquire Syngoi Technologies (“Syngoi”), a Spanish […]
“Industry Pioneer Joins Forces with LongRange Capital to Acquire 24 Hour Fitness. New Owners to Fuel Investment and Expand Business Strength and Success.” CARLSBAD, Calif., Jan. 7, 2026 /PRNewswire/ — 24 Hour Fitness today announced […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of bepirovirsen, an investigational antisense oligonucleotide […]
SAN DIEGO, Jan. 6, 2026 /PRNewswire/ — Novoron Bioscience, a San Diego-based biotechnology company developing therapies for neurodegenerative diseases and neurological injury, has received a $2.5 million Small Business Innovation Research (SBIR) grant from the […]
Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological insights SAN DIEGO, Jan. 6, 2026 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected […]
LA JOLLA, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) provides shareholders a corporate […]
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell therapies for serious medical conditions, today announced the receipt of […]
SAN DIEGO & BOSTON & BILBAO, Spain–(BUSINESS WIRE)–Artis BioSolutions (“Artis”), a San Diego-based advanced-therapies development and manufacturing company, today announced that it has entered into a definitive agreement to acquire Syngoi Technologies (“Syngoi”), a Spanish […]
Atmospheric rivers may be associated with wet winter storms on the West Coast of North America, but these ribbons of water vapor in the sky are a global phenomenon. Now, a new international effort will […]
Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) and Skye Bioscience, Inc. (Nasdaq: SKYE) today announced the companies entered […]
Copyright © 2026 Biotech Networks, LLC
